Your browser doesn't support javascript.
loading
u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression.
Ciavarella, S; Laurenzana, A; De Summa, S; Pilato, B; Chillà, A; Lacalamita, R; Minoia, C; Margheri, F; Iacobazzi, A; Rana, A; Merchionne, F; Fibbi, G; Del Rosso, M; Guarini, A; Tommasi, S; Serratì, S.
Afiliação
  • Ciavarella S; National Cancer Research Centre IRCCS "Giovanni Paolo II", 70124, Bari, Italy.
  • Laurenzana A; Department of Experimental and Clinical Biomedical Sciences, Section of Experimental Pathology and Oncology, University of Florence, Florence, Italy.
  • De Summa S; Molecular Genetics Laboratory, National Cancer Research Centre, IRCCS "Giovanni Paolo II", 70124, Bari, Italy.
  • Pilato B; Molecular Genetics Laboratory, National Cancer Research Centre, IRCCS "Giovanni Paolo II", 70124, Bari, Italy.
  • Chillà A; Department of Experimental and Clinical Biomedical Sciences, Section of Experimental Pathology and Oncology, University of Florence, Florence, Italy.
  • Lacalamita R; Molecular Genetics Laboratory, National Cancer Research Centre, IRCCS "Giovanni Paolo II", 70124, Bari, Italy.
  • Minoia C; National Cancer Research Centre IRCCS "Giovanni Paolo II", 70124, Bari, Italy.
  • Margheri F; Department of Experimental and Clinical Biomedical Sciences, Section of Experimental Pathology and Oncology, University of Florence, Florence, Italy.
  • Iacobazzi A; National Cancer Research Centre IRCCS "Giovanni Paolo II", 70124, Bari, Italy.
  • Rana A; National Cancer Research Centre IRCCS "Giovanni Paolo II", 70124, Bari, Italy.
  • Merchionne F; National Cancer Research Centre IRCCS "Giovanni Paolo II", 70124, Bari, Italy.
  • Fibbi G; Department of Experimental and Clinical Biomedical Sciences, Section of Experimental Pathology and Oncology, University of Florence, Florence, Italy.
  • Del Rosso M; Department of Experimental and Clinical Biomedical Sciences, Section of Experimental Pathology and Oncology, University of Florence, Florence, Italy.
  • Guarini A; National Cancer Research Centre IRCCS "Giovanni Paolo II", 70124, Bari, Italy.
  • Tommasi S; Molecular Genetics Laboratory, National Cancer Research Centre, IRCCS "Giovanni Paolo II", 70124, Bari, Italy.
  • Serratì S; Molecular Genetics Laboratory, National Cancer Research Centre, IRCCS "Giovanni Paolo II", 70124, Bari, Italy. simonaserrati@hotmail.com.
BMC Cancer ; 17(1): 215, 2017 03 24.
Article em En | MEDLINE | ID: mdl-28340565
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ativador de Plasminogênio Tipo Uroquinase / Regulação para Cima / Receptores de Ativador de Plasminogênio Tipo Uroquinase / Fibroblastos Associados a Câncer / Proteínas de Membrana / Mieloma Múltiplo Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: BMC Cancer Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ativador de Plasminogênio Tipo Uroquinase / Regulação para Cima / Receptores de Ativador de Plasminogênio Tipo Uroquinase / Fibroblastos Associados a Câncer / Proteínas de Membrana / Mieloma Múltiplo Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: BMC Cancer Ano de publicação: 2017 Tipo de documento: Article